Correlation Between Inhibrx and Humacyte

Can any of the company-specific risk be diversified away by investing in both Inhibrx and Humacyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Humacyte into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Inhibrx and Humacyte, you can compare the effects of market volatilities on Inhibrx and Humacyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Humacyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Humacyte.

Diversification Opportunities for Inhibrx and Humacyte

0.53

Correlation Coefficient

Inhibrx  Humacyte

Very weak diversification

The 3 months correlation between Inhibrx and Humacyte is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Humacyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Humacyte and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Humacyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Humacyte has no effect on the direction of Inhibrx i.e., Inhibrx and Humacyte go up and down completely randomly.

Pair Corralation between Inhibrx and Humacyte

Given the investment horizon of 90 days Inhibrx is expected to generate 0.48 times more return on investment than Humacyte. However, Inhibrx is 2.07 times less risky than Humacyte. It trades about 0.03 of its potential returns per unit of risk. Humacyte is currently generating about -0.16 per unit of risk. If you would invest  1,224  in Inhibrx on November 29, 2024 and sell it today you would earn a total of  11.00  from holding Inhibrx or generate 0.9% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Inhibrx  vs.  Humacyte

Inhibrx

Risk-Adjusted Performance

Very Weak

Over the last 90 days Inhibrx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain fairly strong which may send shares a bit higher in March 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Humacyte

Risk-Adjusted Performance

Very Weak

Over the last 90 days Humacyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Inhibrx and Humacyte

The main advantage of trading using opposite Inhibrx and Humacyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Humacyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Humacyte will offset losses from the drop in Humacyte's long position.

The idea behind Inhibrx and Humacyte pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..